Published April 30, 2016 This content is archived.
An article in the Buffalo News features the work of Jonathan Lovell, assistant professor of biomedical engineering in the School of Engineering and Applied Sciences, and the promising biotech companies he has co-founded, Abcombi Biosciences, which boosts access to vaccines and allows the vaccines to work more efficiently, and POP Biotechnologies, which uses nanomedicine to find a more reliable way to deliver anti-cancer drugs to tumors.
Read more:
Media Relations (University Communications)
330 Crofts Hall (North Campus)
Buffalo, NY 14260-7015
Tel: 716-645-6969
ub-news@buffalo.edu